PSA as a marker of androgen exposure during pubertal transition in healthy boys
Objective Prostate-specific antigen is an androgen-responsive protein used in adult men as a marker of prostate disease; however, its physiological rise during male puberty is poorly described. We evaluated whether serum prostate-specific antigen may serve as a biomarker of pubertal development in healthy boys and established age-specific reference intervals. Design Longitudinal cohort study. Methods The study included 104 healthy boys and 890 serum samples from the Copenhagen Puberty Study II. Serum prostate-specific antigen was measured by commercial immunoassay. Age-specific reference intervals were developed using generalised additive models for location, scale and shape. Total testosterone and sex hormone-binding globulin were measured by immunoassay. Free testosterone was calculated using the Vermeulen equation. Pubertal onset defined as testicular volume > 3 mL. Boys were categorised by genital stage 1 to 5, and group differences were analysed using linear mixed models. Results Prostate-specific antigen increased from 12 years of age, reaching a median concentration of 0.46 µg/L at 16.5 years, with a reference interval of 0.19 - 0.93 µg/L (model-estimated median ±2 SD). It was undetectable in prepubertal boys and at pubertal onset. A significant increase was observed from genital stage 3, indicating that prostate-specific antigen rose after pubertal onset and later than testosterone. Thresholds of > 3.06 nmol/L for total testosterone and > 36 pmol/L for free testosterone predicted detectable prostate-specific antigen. Conclusion Prostate-specific antigen increased with pubertal progression but was not detectable prior to the onset of puberty, suggesting that a threshold of androgen exposure is required for measurable production.
Authors
- Linda Maria Hilsted (ORCID: https://orcid.org/0000-0003-3465-999X)
- Anders Juul (ORCID: https://orcid.org/0000-0002-0534-4350)
- Lise Aksglæde (ORCID: https://orcid.org/0000-0001-7885-7467)
- Ruth Frikke‐Schmidt (ORCID: https://orcid.org/0000-0003-4084-5027)
- Andrés Felipe Østergaard Fritzbøger (ORCID: https://orcid.org/0009-0001-9816-4091)
- Jørgen Holm Petersen
Institutions
- University of Copenhagen (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- European Journal of Endocrinology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1093/ejendo/lvag212
- Primary Topic
- Hypothalamic control of reproductive hormones
- Type
- article
- Field-Weighted Citation Impact
- 0.00